Literature DB >> 15059879

Alternative lengthening of telomeres is characterized by high rates of telomeric exchange.

J Arturo Londoño-Vallejo1, Héra Der-Sarkissian, Lucien Cazes, Silvia Bacchetti, Roger R Reddel.   

Abstract

Telomere maintenance activity is a hallmark of cancer. In some telomerase-negative tumors, telomeres become lengthened by alternative lengthening of telomeres (ALT), a recombination-mediated DNA replication process in which telomeres use other telomeric DNA as a copy template. Using chromosome orientation fluorescence in situ hybridization, we found that postreplicative exchange events involving a telomere and another TTAGGG-repeat tract occur at remarkably high frequencies in ALT cells (range 28-280/100 metaphases) and rarely or never in non-ALT cells, including cell lines with very long telomeres. Like the ALT phenotype itself, the telomeric exchanges were not suppressed when telomerase was activated in ALT cells. These exchanges are telomere specific because there was no correlation with sister chromatid exchange rates at interstitial locations, and they were not observed in non-ALT Bloom syndrome cells with very high sister chromatid exchange rates.

Entities:  

Mesh:

Year:  2004        PMID: 15059879     DOI: 10.1158/0008-5472.can-03-4035

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  115 in total

1.  Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells.

Authors:  Susan M Bailey; Mark A Brenneman; Edwin H Goodwin
Journal:  Nucleic Acids Res       Date:  2004-07-16       Impact factor: 16.971

2.  Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Authors:  Fang Wang; Yu Yin; Xiaoying Ye; Kai Liu; Haiying Zhu; Lingling Wang; Maria Chiourea; Maja Okuka; Guangzhen Ji; Jiameng Dan; Bingfeng Zuo; Minshu Li; Qian Zhang; Na Liu; Lingyi Chen; Xinghua Pan; Sarantis Gagos; David L Keefe; Lin Liu
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

3.  Maintenance of very long telomeres by recombination in the Kluyveromyces lactis stn1-M1 mutant involves extreme telomeric turnover, telomeric circles, and concerted telomeric amplification.

Authors:  Jianing Xu; Michael J McEachern
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

4.  NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination.

Authors:  Dimitri Conomos; Roger R Reddel; Hilda A Pickett
Journal:  Nat Struct Mol Biol       Date:  2014-08-24       Impact factor: 15.369

5.  Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres.

Authors:  Tania Slatter; Jennifer Gifford-Garner; Anna Wiles; Xin Tan; Yu-Jen Chen; Martin MacFarlane; Michael Sullivan; Janice Royds; Noelyn Hung
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

Review 6.  Telomere biology: integrating chromosomal end protection with DNA damage response.

Authors:  Predrag Slijepcevic; Suliman Al-Wahiby
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

7.  An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres.

Authors:  Yisong Wang; Natalie Erdmann; Richard J Giannone; Jun Wu; Marla Gomez; Yie Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-06       Impact factor: 11.205

8.  Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops.

Authors:  Anthony J Cesare; Jack D Griffith
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

9.  Unusual telomeric DNAs in human telomerase-negative immortalized cells.

Authors:  Akira Nabetani; Fuyuki Ishikawa
Journal:  Mol Cell Biol       Date:  2008-11-17       Impact factor: 4.272

10.  Human POT1 is required for efficient telomere C-rich strand replication in the absence of WRN.

Authors:  Nausica Arnoult; Carole Saintome; Isabelle Ourliac-Garnier; Jean-François Riou; Arturo Londoño-Vallejo
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.